1. Clinical & Scientific Overview
Latanoprost & Travoprost Ophthalmic (PGF2-Alpha Glaucoma Drops) (TIP-MED-000253, Reference Code [12.21]) is classified under
Ophthalmological & Otic (ENT) Preparations (Ch 12) as a Prostaglandin F2-alpha Analogue Ophthalmic Solution (Uveoscleral Outflow Enhancer).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Representative Indian Market Examples (Edition 2.7 Ch 12 [12.21], p. 165): Xalatan, Latoprost, Lacoma, 9PM — Strengths & Dosage Forms: Ophthalmic Solution: 0.005% w/v (50 mcg/mL) in 2.5 mL dropper bottle (alone or FDC with Timolol 0.5%).
Ophthalmic Solution: 0.005% w/v (50 mcg/mL) in 2.5 mL dropper bottle (alone or FDC with Timolol 0.5%).
3. Mechanism of Action & Pharmacodynamics
Selective prostanoid FP receptor agonist -> upregulates ciliary muscle matrix metalloproteinases -> remodels extracellular matrix and increases uveoscleral outflow of aqueous humour (reduces IOP by 25-35%).
4. Therapeutic Indications & Evidence-Supported Uses
- First-line monotherapy for open-angle glaucoma and ocular hypertension
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Adult: 1 drop into the affected eye(s) ONCE DAILY in the evening (around 9 PM). Do NOT instill more than once daily (more frequent dosing reduces IOP-lowering effect!). • Paediatric: Paediatric Glaucoma: 1 drop once nightly.
Administration & Meal Timing: See Administration & Counselling below. | Standard clinical schedule per indication.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: No adjustment required. • Hepatic: No adjustment required.
Renal: No adjustment required. • Hepatic: No adjustment required.
Renal: No adjustment required. • Hepatic: No adjustment required.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindications: Hypersensitivity to latanoprost or benzalkonium chloride; active herpetic keratitis. • Precautions: Causes gradual, permanent increased brown pigmentation of the iris (In mixed-colour irises) and reversible darkening/lengthening of eyelashes; caution in aphakia/pseudophakia with torn posterior capsule (risk of cystoid macular oedema) and uveitic glaucoma.
Key Clinical Precautions: Renal: No adjustment required. • Hepatic: No adjustment required.
8. Adverse Effects Profile
- Conjunctival hyperaemia, eyelash growth/darkening (hypertrichosis), iris hyperpigmentation, periocular skin darkening, punctate keratitis.
- Cystoid macular oedema, reactivation of herpes simplex keratitis, anterior uveitis.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Thimerosal-containing eye drops -> precipitates if instilled within 5 minutes; remove soft contact lenses before instilling (benzalkonium chloride preservative is absorbed by soft lenses—reinsert after 15 minutes)
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Instill 1 drop ONCE every evening (using it twice daily makes it work LESS effectively); remove contact lenses before putting drops and wait 15 minutes before reinserting; wipe away any excess liquid on cheek to prevent dark skin circles.
- Meal & Clock Timing Instruction: See Administration & Counselling below. (Standard clinical schedule per indication.)
- Missed Dose Protocol: Take as soon as remembered unless close to next scheduled dose; never double the dose.
- Geriatric Dispensing Pearl: Schedule: Schedule H | NLEM 2022: Yes | Compendia: IP 2026 / NFI 7th Ed 2026 / NLEM 2022 / CDSCO Schedule H / BNF 90th Ed
Storage, Stability & Dispensing Safeguards: COLD CHAIN MANDATORY (2°C–8°C): Store in a pharmaceutical refrigerator between 2°C and 8°C; DO NOT FREEZE. Protect from light and heat during dispensing.
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 12 [12.21] (p. 165)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [12.30] Otic Ciprofloxacin, Clotrimazole & Cerumenolytic Ear Drops — Topical Otic Fluoroquinolone, Imidazole Antifungal, Corticosteroi
- [12.5]-C150 Brimonidine Tartrate — Topical Ophthalmic Beta-Blockers (Timolol), Prostaglandin Analogu
- [12.5]-C151 Dorzolamide / Moxifloxacin Ophthalmic Drops — Topical Ophthalmic Beta-Blockers (Timolol), Prostaglandin Analogu
- [12.5]-CMP152 Tobramycin 0.3% & Ciprofloxacin 0.3% Ophthalmic Drops / Ointment IP — Topical Ophthalmic Beta-Blockers (Timolol), Prostaglandin Analogu